Anti-NR2C1 monoclonal antibody

Pre-made anti-NR2C1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NR2C1/NR2C1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2631-Ab-1/ GM-Tg-hg-IP2631-Ab-2Anti-Human NR2C1 monoclonal antibodyHuman
GM-Tg-rg-IP2631-Ab-1/ GM-Tg-rg-IP2631-Ab-2Anti-Rat NR2C1 monoclonal antibodyRat
GM-Tg-mg-IP2631-Ab-1/ GM-Tg-mg-IP2631-Ab-2Anti-Mouse NR2C1 monoclonal antibodyMouse
GM-Tg-cynog-IP2631-Ab-1/ GM-Tg-cynog-IP2631-Ab-2Anti-Cynomolgus/ Rhesus macaque NR2C1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2631-Ab-1/ GM-Tg-felg-IP2631-Ab-2Anti-Feline NR2C1 monoclonal antibodyFeline
GM-Tg-cang-IP2631-Ab-1/ GM-Tg-cang-IP2631-Ab-2Anti-Canine NR2C1 monoclonal antibodyCanine
GM-Tg-bovg-IP2631-Ab-1/ GM-Tg-bovg-IP2631-Ab-2Anti-Bovine NR2C1 monoclonal antibodyBovine
GM-Tg-equg-IP2631-Ab-1/ GM-Tg-equg-IP2631-Ab-2Anti-Equine NR2C1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2631-Ab-1/ GM-Tg-hg-IP2631-Ab-2; GM-Tg-rg-IP2631-Ab-1/ GM-Tg-rg-IP2631-Ab-2;
GM-Tg-mg-IP2631-Ab-1/ GM-Tg-mg-IP2631-Ab-2; GM-Tg-cynog-IP2631-Ab-1/ GM-Tg-cynog-IP2631-Ab-2;
GM-Tg-felg-IP2631-Ab-1/ GM-Tg-felg-IP2631-Ab-2; GM-Tg-cang-IP2631-Ab-1/ GM-Tg-cang-IP2631-Ab-2;
GM-Tg-bovg-IP2631-Ab-1/ GM-Tg-bovg-IP2631-Ab-2; GM-Tg-equg-IP2631-Ab-1/ GM-Tg-equg-IP2631-Ab-2
Products NameAnti-NR2C1 monoclonal antibody
Formatmab
Target NameNR2C1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NR2C1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2631-Ag-1Recombinant multi-species NR2C1/ TR2 protein


    Target information

    Target IDGM-IP2631
    Target NameNR2C1
    Gene ID7181,22025,252924,716524,611980,101081907,511407,100052073
    Gene Symbol and Synonyms4831444H07Rik,80.3,Eenr,NR2C1,Psg4,TR2,Tr2-11
    Uniprot AccessionP13056,Q8VIJ4,A0JNE3
    Uniprot Entry NameNR2C1_HUMAN,NR2C1_RAT,NR2C1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000120798
    Target ClassificationN/A

    The target: NR2C1, gene name: NR2C1, also named as TR2. This gene encodes a nuclear hormone receptor characterized by a highly conserved DNA binding domain (DBD), a variable hinge region, and a carboxy-terminal ligand binding domain (LBD) that is typical for all members of the steroid/thyroid hormone receptor superfamily. This protein also belongs to a large family of ligand-inducible transcription factors that regulate gene expression by binding to specific DNA sequences within promoters of target genes. Multiple alternatively spliced transcript variants have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.